Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOA1 anticorps

APOA1 Reactivité: Humain RIA, EIA Hôte: Souris Monoclonal 1404 unconjugated
N° du produit ABIN111087
  • Antigène Voir toutes APOA1 Anticorps
    APOA1 (Apolipoprotein A-I (APOA1))
    Reactivité
    • 116
    • 39
    • 23
    • 10
    • 10
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 90
    • 48
    • 18
    • 5
    • 3
    • 3
    • 2
    Souris
    Clonalité
    • 114
    • 53
    Monoclonal
    Conjugué
    • 83
    • 33
    • 15
    • 13
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Cet anticorp APOA1 est non-conjugé
    Application
    • 107
    • 81
    • 44
    • 21
    • 17
    • 14
    • 12
    • 11
    • 9
    • 8
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Radioimmunoassay (RIA), Enzyme Immunoassay (EIA)
    Specificité
    Hihgly specific for APO A-I, no cross reactivity with APO A-II or Apo B.Aff. Const.:8 x 10e9
    Purification
    DEAE-chromatography
    Immunogène
    Purified human plasma Apo A-I
    Clone
    1404
    Isotype
    IgG1
    Top Product
    Discover our top product APOA1 Anticorps primaire
  • Indications d'application
    Competeitive RIA. ELISA.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    3.84 mg/mL (OD280 nm, E1% = 14)
    Buffer
    0.015 M PBS, 0.15 M NaCl, pH 7.2 with 0.09 % Sodium Azide as preservative
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    APOA1 (Apolipoprotein A-I (APOA1))
    Autre désignation
    Apolipoprotein A I (APO AI) (APOA1 Produits)
    Synonymes
    anticorps Alp-1, anticorps Apoa-1, anticorps Brp-14, anticorps Ltw-1, anticorps Lvtw-1, anticorps Sep-1, anticorps Sep-2, anticorps Sep2, anticorps apoA-I, anticorps apoa, anticorps apoa1, anticorps cb49, anticorps wu:fb33f01, anticorps zgc:103718, anticorps MGC64335, anticorps MGC89745, anticorps Apo-AI, anticorps ApoA-I, anticorps APOA1, anticorps LOC100136573, anticorps apoa-i, anticorps ApoAI, anticorps apolipoprotein A1, anticorps apolipoprotein A-I, anticorps apolipoprotein A-Ia, anticorps apolipoprotein A-I S homeolog, anticorps apolipoprotein A4, anticorps APOA1, anticorps Apoa1, anticorps apoa1a, anticorps apoa1.S, anticorps apoa1, anticorps LOC100136573, anticorps apoa-i, anticorps apoa4
    Sujet
    Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids, an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI
    ID gène
    335
    NCBI Accession
    NP_000030
    UniProt
    P02647
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Vous êtes ici:
Support technique